The Capecitabine market is experiencing growth due to increasing demand for effective chemotherapy treatments, particularly in colorectal and breast cancer.…
NANJING, China, Sept. 5, 2024 /PRNewswire/ — On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets…
Harnessing automated tracking, proactive communication, and cost-optimisation solutions to redefine their international freight operations SINGAPORE, Sept. 5, 2024 /PRNewswire-PRWeb/ —…